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1Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD 4072, AustraliaABSTRACT Genome-scale models are used for an ever-widening range of applications. Although there has been much focus
on specifying the stoichiometric matrix, the predictive power of genome-scale models equally depends on reaction directions.
Two-thirds of reactions in the two eukaryotic reconstructions Homo sapiens Recon 1 and Yeast 5 are specified as irreversible.
However, these specifications are mainly based on biochemical textbooks or on their similarity to other organisms and are rarely
underpinned by detailed thermodynamic analysis. In this study, a to our knowledge new workflow combining network-embedded
thermodynamic and flux variability analysis was used to evaluate existing irreversibility constraints in Recon 1 and Yeast 5 and to
identify new ones. A total of 27 and 16 new irreversible reactions were identified in Recon 1 and Yeast 5, respectively, whereas
only four reactions were found with directions incorrectly specified against thermodynamics (three in Yeast 5 and one in
Recon 1). The workflow further identified for both models several isolated internal loops that require further curation. The frame-
work also highlighted the need for substrate channeling (in human) and ATP hydrolysis (in yeast) for the essential reaction cata-
lyzed by phosphoribosylaminoimidazole carboxylase in purine metabolism. Finally, the framework highlighted differences in
proline metabolism between yeast (cytosolic anabolism and mitochondrial catabolism) and humans (exclusively mitochondrial
metabolism). We conclude that network-embedded thermodynamics facilitates the specification and validation of irreversibility
constraints in compartmentalized metabolic models, at the same time providing further insight into network properties.INTRODUCTIONGenome-scale metabolic models (GeMs) have been recon-
structed for many model organisms, including Escherichia
coli, Saccharomyces cerevisiae, Mus musculus, Homo
sapiens, and Arabidopsis thaliana (1–5). These models
enable a systematic approach to investigating genotype-
phenotype relationships at the metabolic level (6), and
they are applied in a variety of research fields, such as meta-
bolic engineering (7).
Each reconstruction in principle captures the complete
metabolic capabilities of a given organism. These metabolic
capabilities are explored by flux balance analysis (FBA)
using the topological constraints (e.g., reaction connectivity
and reversibility) contained within the reconstruction (8).
The flux balances greatly reduce the dimension of the solu-
tion space, but GeMs still have hundreds of degrees of
freedom, and directional constraints are critical to the pre-
dictive powers of the models. The quality of predictions im-
proves as more constraints are specified (9). Conversely,
erroneous irreversibility constraints can result in incorrect
flux predictions (10).
Reaction directionality can be specified from the Gibbs
energy of reaction (DrG) using the second law of thermody-
namics. The range of DrG can be calculated from estimates
of standard Gibbs energy and physiological ranges ofSubmitted September 17, 2013, and accepted for publication May 19, 2014.
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0006-3495/14/07/0493/11 $2.00metabolite concentrations. The range of DrG has been
used to assign directionality to individual reactions in
E. coli iJR904 (11), E. coli iAF1260 (12), and H. sapiens
Recon 1 (13).
Through the network topology, individual irreversible
reactions may dictate the direction of otherwise reversible
reactions and the range of feasible metabolite concentra-
tions. Accordingly, thermodynamic constraints can propa-
gate widely in the network. Network thermodynamics was
first exploited in the 1990s to analyze glycolysis (14).
More recently, network-embedded thermodynamic analysis
(NET analysis) (15) has enabled analysis of large-scale
networks using nonlinear optimization.
NET analysis was developed to assess whether experi-
mentally derived metabolite concentrations are feasible
with respect to the reaction directionalities. In this study,
we use NET analysis in reverse to assign reaction direc-
tionalities based on physiological ranges of metabolite
concentrations and thermodynamic constraints in two
eukaryotic GeMs, namely, H. sapiens Recon 1 (3) and
Yeast 5 (16). Erroneous irreversibility constraints were
found in both models, whereas several new constraints
revealed unconnected loops in the models. The analysis
also enabled resolution of the different compartmentali-
zation of L-proline metabolism in humans and yeast. A
new open-source software, NExT, was developed to
implement correct estimations of Gibbs energy for trans-
port reactions.http://dx.doi.org/10.1016/j.bpj.2014.05.029
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Calculation of Gibbs energy (DG)
The estimation of Gibbs energy of formation (DfG) was adjusted for phys-
iological conditions of pH and ionic strength. For reactions coupled to
transport (e.g., ATP synthase), the differences in pH and redox potential
were taken into account (17). The full description of the DG calculations
can be found in the Supporting Material.NET analysis
For biological systems where constant temperature and pressure applies, the
second law of thermodynamics states that spontaneity is defined by negative
Gibbs free energy (DG< 0). Therefore, for biochemical reactions, the reac-
tion occurs only in the direction where DrG is negative. DrG depends on
metabolite concentrations and the standard Gibbs energy of reaction
(DrG
0), the latter of which is determined from the standard Gibbs energy
of formation of the components (DfG
0) and the stoichiometric coefficients.
NETanalysis (15) applies thermodynamic principles to a complete meta-
bolic network simultaneously to check the thermodynamic feasibility of a
metabolite data set, estimate feasible ranges for unmeasured metabolites,
and assign reaction directions. The algorithm integrates the second law of
thermodynamics and DfG
00 with a stoichiometric model (defined by a
stoichiometric matrix S and reaction directionalities):
min

max DrG
0
k (1)
subject to DrG
0
j<0c rj>0 (2)DrG
0
j>0c rj<0 (3)DrG
0
j ¼
X
SijDfG
0
i (4)i
DfG
0
i¼ DfG00i þ RTLnðciÞ (5)cmini %ci%c
max
i : (6)By minimizing and maximizing DrG’ of each reaction k (Eq. 1), the range
of DrG’k is estimated for all reactions. Equations 2 and 3 impose thermody-
namic constraints for irreversible reactions, and Eqs. 4 and 5 describe the
calculation of DrG’. The measured metabolite concentrations and the phys-
iological range of concentrations are expressed in Eq. 6; the range of
cofactor ratios can also be incorporated as constraints. In an analogous pro-
cess, the feasible range of metabolite concentrations can be calculated (15).
If a reaction specified to be reversible in the model has its maximum DrG
calculated to be negative, the reaction operates strictly in the forward direc-
tion. Conversely, if the minimum DrG is positive, the reaction operates
strictly in the reverse direction. No direction can be inferred when the
DrG minimum is negative and the maximum is positive. Our Matlab
implementation of NET analysis, NExT, is available from http://web.aibn.
uq.edu.au/cssb/Resources.html.Workflow to thermodynamically curate
a metabolic model
A novel workflow for the thermodynamic curation of GeMs was developed
(Fig. 1). The following information and data are required as inputs:
 a metabolic model (which represents the metabolic reactions with their
directions and the specific compartment where each reaction takes place);Biophysical Journal 107(2) 493–503 biophysical properties of cellular compartments (pH, ionic strength, etc.);
 thermodynamic properties (standard free energy of formation, charge,
and number of hydrogen atoms of the reactants); and
 physiological metabolite concentrations.
The workflow is divided into two stages: de novo predictions without
using directional specifications from the GeM and predictions using the
full GeM. In the first stage, NExT identifies purely thermodynamic con-
straints (Fig. 1, Step 1). These constraints are compared to the directionality
constraints specified in the GeM to identify new constraints and correct any
inconsistent constraints. In the second step, flux variability analysis (FVA)
is used to identify topologically blocked reactions (Fig. 1, Step 2). Finally, a
second FVA, including the thermodynamic constraints from Step 1, is used
to identify additional irreversible reactions, which we call topologically
irreversible reactions (Fig. 1, Step 3). For example, reactions belonging
to a linear pathway become topologically irreversible when one reaction
of the pathway is thermodynamically irreversible.
The new, reconciled thermodynamic constraints are carried forward to
the second stage, where the directionality constraints from the GeM are
integrated in NExT (Fig. 1, Step 4). Using the full set of constraints,
metabolite concentration ranges are narrowed, and consequently further
thermodynamic constraints are identified. A final FVA using the GeM direc-
tionality constraints is used to identify reactions that are either blocked or
irreversible due to the GeM topology (Fig. 1, Step 5). A final comparison
between thermodynamic constraints and FVA predictions is used to identify
needs for further curation.Metabolic models and assumptions
The human GeM H. sapiens Recon 1 (3) and Yeast 5 GeM (16) were modi-
fied as follows to make them suitable for thermodynamic calculations.
1), Reactions that are catalyzed by different enzymes in either direction
were lumped together, otherwise a thermodynamic equilibrium state with
a zero Gibbs energy of reaction would be considered for both of them.
2), The species HCO3, CO32, CO2, and H2CO3 were aggregated as
the reactant CO2tot, since carbon dioxide is distributed among these species
in aqueous phase (H2O was added to the other side of the reaction to
balance oxygen atoms) (18). 3), The oxidized and reduced FAD of mito-
chondria were replaced by the oxidized and reduced FADenz to represent
the enzyme-bound FAD cofactor (18).Biophysical compartment properties
Literature values for compartment-specific biophysical properties (pH,
redox potential, ionic strength, and size) were used in the calculations of
DrG to represent real physiological conditions (Table 1 and Table S1 in
the Supporting Material). Mitochondrial and cytosolic accurate biophysical
properties were found in the literature (15,19–23); and for the remaining
compartments, the same properties were assumed as for the cytosol (with
the exception of size), keeping the model stoichiometrically intact.Physiological range of metabolite concentrations
The concentrations for all metabolites were assumed to be between
0.0001mMand 10mM to represent the range of observed physiological con-
centrations (13,15). Exceptions were made for oxygen, carbon dioxide, and
inorganic phosphate (Table 1). In addition, an arbitrarily wide range of con-
centration ratios were specified for the adenylate energy charge (AEC) and
the redox cofactors (i.e., NADþ/NADH and NADPþ/NADPH) (Table 1).Physical and chemical metabolite properties
To calculate the Gibbs energy of reactions, the following information was
needed for all reactants in the network: standard Gibbs energy of formation
FIGURE 1 Methodology workflow. A five-steps process is used to generate a thermodynamically curated metabolic model. The first step (NExT topology)
identifies thermodynamic constraints, which are compared with the model specifications. Step 2 (FVA prethermodynamics) identifies blocked reactions
caused solely by network topology; together with the results from step 1, blocked thermodynamically irreversible reactions are thus identified. Step 3
(FVA post thermodynamics) identifies the reduction of the solution space due to thermodynamic constraints. Step 4 (NExT GeM) identifies new thermody-
namic constraints that are a consequence of network-specified directionality constraints; the metabolite concentration ranges are also thermodynamically
constrained. Step 5 (FVA GeM) identifies the solution space of the model using network-specified directionality constraints only, which are compared
with results of step 4 to identify the new thermodynamic constraints that will reduce the flux solution space. Inputs to the process are in green boxes, outputs
in purple boxes, and information inferred in orange boxes; simulations are in blue ovals.
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0), number of hydrogen atoms, and charge. The thermodynamic prop-
erties for 186 metabolites were obtained from published data (24). For
metabolites for which we found no published DfG
0 values, a separate
algorithm based on the group contribution method was used to estimate
DfG
0 (25,26). In addition, the number of hydrogen atoms and the charge
of metabolites at physiological conditions were collected from the literature
(15,26–29). The final database contains information for 860 metabolites
(Table S2).RESULTS AND DISCUSSION
Software implementation of NET analysis
NET analysis has previously been implemented in the soft-
ware anNET (30). A new software, NExT, was developed to
implement corrections regarding how transport reactions are
handled. First, when calculating the DrG of reactions
coupled to transport (e.g., ATP synthase), anNET only con-siders the transport part (e.g., proton transport) and not the
reaction part (e.g., ATP synthesis). H. sapiens Recon 1 has
almost 50 transport coupled reactions, so it was important
to correct the erroneous calculations. Second, we made
the necessary corrections for the transport of weak acids
and bases, i.e., reactants composed of multiple proton-
bound species in rapid equilibrium (e.g., lactate and lactic
acid), allowing for the different equilibria in compartments
that differ in pH (17). For a given external concentration, the
corrections significantly affect the feasible internal concen-
trations of many transported weak acids and bases.
ATP synthase was affected by both modifications as an
intercompartment enzyme that produces ATP using the
energy generated from proton motive force. Although pro-
tons are exchanged between the mitochondrial matrix
and the mitochondrial intermembrane space (IMS), thisBiophysical Journal 107(2) 493–503
TABLE 1 Biophysical properties and concentration ranges
Human Yeast
pH, cytosol 7.4a 7b
Redox potential, cytosol 315 mVc 286 mVd
pH, mitochondria 7.98a 7.4b
Redox potential, mitochondria 360 mVe 296 mVd
pH, IMS 6.7f 6.3f
Redox potential, IMS 242g 213d
Ionic strength 0.15 Mb
Oxygen concentration (mM) [104;0.1]
[CO2], [Pi], [Ppi] (mM) [1;100]
b
Other reactants (mM) [104,10]b,h
Adenylate energy charge (AEC) [104,10]b
NADH/NAD ratio [104,10]
NADPH/NADP ratio [104,10]
aValues from Llopis et al. (21).
bValues from Kummel et al. (15).
cValues from Bjo¨rnberg et al. (19).
dValues from Hu et al. (20).
eValue from Hanson et al. (23).
fValues from Porcelli et al. (22), considering 0.7 units lower than
cytosolic pH.
gThe variation between redox potential in cytosol and IMS of yeast was
used as a reference.
hValue from Haraldsdo´ttir et al. (13).
496 Martı´nez et al.exchange is commonly treated as protons being transported
to and from the cytoplasm. Given the moderate differences
in pH and redox potential between the cytoplasm and mito-
chondria observed for both yeast and humans (Table 1), the
reaction DrG’
0 becomes positive (10.57 and 25.15 KJ/mol
for the human and yeast models, respectively (Table S3)).
This value translates into a nonphysiological, low maximum
mitochondrial ATP concentration (0.014 and 0.00004 mM
for human and yeast cells, respectively). This was not
apparent in anNET, since it ignores ATP production when
estimating the DrG’
0 of ATP synthase (see Eq. S11) (30),
which is the thermodynamically unfavorable part of the
reaction (DrG’
0
compartment values for producing ATP are
41.20 and 38.14 KJ/mol for the human and yeast models,
respectively (Table S3)).
To allow the ATP synthase reaction to function as ex-
pected, it must be written with the consideration of proton
flux from the IMS rather than the cytoplasm. The IMS itself
has a much lower pH and a more oxidizing environment
(Table 1) compared to the cytoplasm (20,22). With this
modification, the concentration of mitochondrial ATP is
not constrained by ATP synthase, thus rendering the model
thermodynamically feasible (see Table S3 for the new DrG’
0
when protons are transported from the IMS). The change
from compartmentalization of protons in the cytoplasm to
compartmentalization in the IMS was performed on all reac-
tions involved in oxidative phosphorylation to maintain con-
sistency of the model. Transporters involved in solute
transport between the cytoplasm and mitochondria (e.g.,
mitochondrial pyruvate transporter) are written as such
without an intermediate IMS stage.Biophysical Journal 107(2) 493–503The NExT software is provided in an open-source format
to enable facile modification and integration with other
workflows by the community. The software and corrected
GeMs are available from http://web.aibn.uq.edu.au/cssb/
Resources.html.Prediction of irreversible reactions in H. sapiens
Recon 1
This work uses the H. sapiens Recon 1 GeM (3) rather
than the recently published Recon 2 (31), since initial
releases of the latter contained a number of errors. All of
the observations made below, however, have been cross-
checked against the current database, Recon X (http://
humanmetabolism.org/), and, unless otherwise stated,
remain true as of September 1, 2013. The IMS compartment
was introduced in Recon 1 for oxidative phosphorylation.
Additional minor modifications to equations were made to
enable accurate calculations (see Materials and Methods).
Excluding artificial boundary exchange reactions, the modi-
fied model contains 1160 reversible reactions and 2149 re-
actions defined as irreversible. Biophysical properties
were specified based on literature values, whereas broad
concentration ranges and ratio ranges for adenylate energy
charge and redox factors were used (Table 1).
De novo predictions
The novel framework used for curation of GeMs, introduced
in Materials and Methods, is summarized in Fig. 1. We first
used NExT to identify irreversible reactions without using
the 2149 irreversibilities already specified in Recon 1
(Fig. 1, Step 1). Using broad concentration ranges (Table 1),
a total of 319 reactions were found to be irreversible under
physiological conditions. Of these irreversible reactions,
306 were among the 2149 specified in Recon 1, whereas
the remaining 13 are new irreversibility constraints not pre-
viously specified in the GeM (Table 2).
Even in the absence of irreversibility constraints, 525 of
3711 reactions in the human model are linked to singleton
(dead-end) metabolites, i.e., metabolites unable to carry
any flux (Fig. 1, Step 2). Of the 319 irreversible reactions
predicted, 77, including one of the 13 new irreversible reac-
tions (P450SCC1m), cannot carry flux. Thermodynamically
constraining these 77 reactions will not further reduce the
solution space.
Introducing the remaining 242 irreversibility constraints
caused an additional 27 reactions to lose the ability to carry
flux, whereof 17 were also unable to carry flux in the
constrained Recon 1 (see Table S4) (Fig. 1, Step 3). The
additional 10 reactions unable to carry flux belonged to
the purine metabolism pathway producing inosine mono-
phosphate (IMP) from 5-phosphoribosyl-1-pyrophosphate
(PRPP) and glutamine. In the model, flux through this essen-
tial pathway is prevented by the reaction catalyzed by
phosphoribosylaminoimidazole carboxylase (AIRCr) being
TABLE 2 Reactions identified as irreversible by thermodynamic constraints in Recon1 that were not specified as such in the model
ID Reaction DrG min (KJ/mol) DrG max (KJ/mol) Direction Pathway
P450SCC1ma [m]chsterol þ h þ nadph þ o2 ¼ 20ahchsterol þ
h2oþnadp
427.91 302.34 Forward Cholesterol metabolism
AIRCrb [c]air þ co2tot ¼ 5aizc þ h þ h2o 3.17 71.67 Reverse IMP biosynthesis
G5SADrm [m]glu5sa ¼ 1pyr5c þ h þ h2o 94.29 37.21 Forward Arginine and proline metabolism
PHCHGSm [m]1p3h5c þ h þ h2o ¼ 4hglusa 44.75 101.83 Reverse Arginine and proline metabolism
GTHP [c] (2)gthrd þ h2o2 ¼ gthox þ (2)h2o 316.29 202.13 Forward Glutathione metabolism
GTHPe [e] (2)gthrd þ h2o2 ¼ gthox þ (2)h2o 316.29 202.13 Forward Glutathione metabolism
GTHPm [m] (2)gthrd þ h2o2 ¼ gthox þ (2)h2o 316.29 202.13 Forward Glutathione metabolism
DPGM [c]13dpg ¼ 23dpg þ h 70.55 13.47 Forward Glycolysis /gluconeogenesis
DCMPDA [c]dcmp þ h þ h2o ¼ dump þ nh4 87.76 2.14 Forward Pyrimidine catabolism
DCT [c]L_dpchrm ¼ 56dihindlcrbxlt 119.48 62.40 Forward Tyrosine metabolism
DOPAQNISO1 [c]dopaqn ¼ 2c23dh56dhoxin þ h 86.28 29.20 Forward Tyrosine metabolism
PDX5PO [c]o2 þ pdx5p ¼ h2o2 þ pydx5p 162.89 65.86 Forward Vitamin B6 metabolism
PYAM5POr [c]h2o þ o2 þ pyam5p ¼ h2o2 þ nh4 þ pydx5p 193.98 68.41 Forward Vitamin B6 metabolism
See Supporting Material for analysis of errors in estimated values.
aLinked to singleton metabolite and cannot carry flux.
bAIRCr is treated in a separate section.
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direction, which contradicts both the essential requirement
for flux through the pathway and the thermodynamic direc-
tion of the reaction glutamine phosphoribosyldiphosphate
amidotransferase. AIRCr will be discussed in a separate
section below, where it will become clear that it is not ther-
modynamically constrained. Hence, the prediction will be
excluded from further analysis.
Apart from preventing flux through 27 reactions, the
introduction of 242 thermodynamic constraints within the
network caused an additional 307 reactions to be topologi-
cally irreversible (Fig. 1, Step 3). These reactions include
two that are a direct consequence of the new thermodynamic
constraints added into the model; the directions of
mitochondrial L-1-pyrroline-3-hydroxy-5-carboxylate de-
hydrogenase (PHCDm) and mitochondrial L-4-hydroxyglu-
tamate semialdehyde dehydrogenase (4HGLSDm) were
fixed by the direction of mitochondrial L-1-pyrroline-3-hy-
droxy-5-carboxylate (PHCHGSm), since the three reactions
form an unbranched pathway.
Predictions using the full GeM
Using NET analysis without including any prior irrevers-
ibility constraints is equivalent to testing each reaction in
the network independently using the metabolite ranges
specified in Table 1. NET analysis uses separately specified
irreversibility constraints implicitly to further constrain the
metabolite range, thereby potentially identifying additional
irreversible reactions. Such an approach must be used with
care, since errors in DfG estimates or irreversibility assump-
tions can propagate widely. Moreover, the algorithm uses
constraints from all reactions, whether or not they are active
under specific growth conditions.
NExT was used to identify new irreversible reactions
when including 2032 of the 2149 irreversibilities already
specified in Recon 1 (Fig. 1, Step 4). To avoid unreal con-
straints, the 118 irreversible transport reactions betweenthe compartments with assumed biophysical properties
equal to those of cytoplasm were set to be reversible.
First, the DrG range was determined for 926 of 2032 irre-
versible reactions for which sufficient information was
available, i.e., where DfG was available for all reactants.
All 926 specified reaction directions were thermodynami-
cally feasible under the broad conditions specified in Ta-
ble 1. Of 1277 reactions specified as reversible in Recon
1, 701 could be thermodynamically assessed. In addition
to the 12 reactions (ignoring AIRCr, as discussed above)
already found to be irreversible given broad concentration
constraints (Table 2), an additional 18 reactions labeled as
reversible were identified as thermodynamically irrevers-
ible when the Recon 1 constraints were included
(Fig. 1, Step 4).
The new irreversibility constraints are caused by sur-
rounding irreversibility constraints limiting substrate or
product concentration ranges. The sources of these con-
straints were further analyzed to establish whether they
came from a reliable source. The initial list of new irrevers-
ible reactions included four enzymes normally considered
reversible (three nucleotide phosphatases (NPs) and a phos-
phopentomutase). All four were made irreversible through
the model specification that NP1 (another NP activity) is
irreversible, which dictates a minimal ribose-1-phosphate
(R1P) concentration of 2 mM and a maximum inorganic
phosphate concentration of 5 mM. The source for the irre-
versibility specification for NP1 is unclear; it is not found
in any standard database, including Recon X. Nicotinate
incorporation in the NAD salvage pathway is normally re-
ported to use NAPRT1 (EC 2.4.2.11), which uses PRPP
instead of R1P. Moreover, the exact same enzyme (EC
2.4.2.1) is known to work in the opposite direction for other
substrates (purine nucleosides, nicotinate-D-riboside).
Given the unlikely high predictions for the minimal
R1P concentration and direction of other nucleotide phos-
phorylases, NExT was rerun without the NP1 specification,Biophysical Journal 107(2) 493–503
498 Martı´nez et al.leading to the identification of 13 irreversible reactions
(Table 3).
The causes for the 10 new irreversible reactions were
further analyzed. The 4HGLSDm reaction was predicted
to be irreversible. This reaction was also identified by Har-
aldsdo´ttir et al. (13), and the same enzyme catalyzes other
irreversible reactions, including those of 1-pyrroline-5-
carboxylate dehydrogenase (P5CD) and PHCD. Indeed,
NExT predicts irreversibility of 4HGLSDm on the basis
of PHCDm constraining the mitochondrial NADH/NAD
ratio.
Mitochondrial L-lactate transport through the proton sym-
port (L-LACtm) is made irreversible by the inclusion of an
irreversible facilitated transport reaction for lactate into
mitochondria through a broad selectivity neutral solute
channel (AQP9). Although the transport specification in
Recon 1 is incorrect (AQP9 only transports the neutral acid
form), the correct transporter would have the same effect if
irreversibility is accepted. There is, however, limited basis
for the latter considering that the existence of mitochondrial
lactate oxidation is still subject to debate (32).
Glutathione transport into mitochondria (GTHRDt)
becomes irreversible because the estimated minimum cyto-
solic ATP concentration is ~0.5 mM. This estimate is well
below the reported minimum value of 1.29 mM (13) and
thus is a reasonable constraint. It should be noted that gluta-
thione is only transported to mitochondria to establish the
glutathione pool; redox cycling is performed internally.
Reaction fatty-acid-CoA ligase hexadecenoate
(FACOAL161) becames irreversible due to a reduced range
of AEC, caused by other irreversible reactions. Finally, a
number of cytosolic aldehyde dehydrogenases used in
vitamin A and tyrosine metabolism were found to be irre-
versible in the oxidation direction. The constraints areTABLE 3 Reactions that were identified as irreversible by NExT co
already specified in the model
ID Reaction
4HGLSDm [m]e4hglu þ (2)h þ nadh ¼ 4hglusa þ h2o
L_LACtm h[c] þ lac_L[c] ¼ h[m] þ lac_L[m]
GTHRDt atp[c] þ gthrd[c] þ h2o[c] ¼ adp[c] þ gthrd[m] þ
RADH [c]h2o þ nad þ retinal ¼ (2)h þ nadh þ
RADH2 [c]h2o þ nadp þ retinal ¼ (2)h þ nadph þ
RADH3 [c]h2o þ nad þ retinal_cis_13 ¼ 13_cis_retn þ (
RADH4 [c]h2o þ nadp þ retinal_cis_13 ¼ 13_cis_retn þ (
3M4HDXPAC [c]3mox4hpac þ h2o þ nad ¼ (2)h þ homova
34DHPLACOX_NADP [c]34dhpac þ h2o þ nadp ¼ 34dhpha þ (2)h
34DHXMANDACOX_
NADP
[c]34dhmald þ h2o þ nadp ¼ 34dhoxmand þ (2
3MOX4HOXPGALDOX_
NADP
[c]3m4hpga þ h2o þ nadp¼ 3mox4hoxm þ (2)
4HOXPACDOX_NADP [c]4hoxpacd þ h2o þ nadp ¼ 4hphac þ (2)h
FACOAL161 [c]atp þ coa þ hdcea ¼ amp þ hdcoa þ
See Supporting Material for analysis of errors in estimated values.
Biophysical Journal 107(2) 493–503caused by a reduced range of cytosolic redox ratios due to
other irreversible dehydrogenases. The irreversibility of
retinal dehydrogenase was reported previously (13), using
a narrower initial concentration range for the dinucleotides.
The four NADP-linked aldehyde dehydrogenases are all
catalyzed by ALDH3 (EC 1.2.1.5), and one of these
(4HOXPACDOX_NADP) is topologically constrained to
operate only in the forward direction; thus, it is reasonable
to assume that all four reactions are thermodynamically
constrained in this direction under normal conditions.
Reaction directionalities obtained from thermodynamics
(Tables 2 and 3) were compared with the direction of
fluxes generated by FVA (Fig. 1, Step 5). Six reactions
(PHCHGSm, GTHPm, DPGM, DCT, 4HOXPACDOX_
NADP, and DOPAQNISO1) were found to be GeM
topologically irreversible in the same direction as the
thermodynamic constraints. On the other hand, five
reactions (AIRCr, 4HGLSDm, 34DHPLACOX_NADP,
34DHXMANDACOX_NADP, and 3MOX4HOXPGAL
DOX_NADP) showed inconsistency in terms of the direc-
tionality calculated by FVA and thermodynamics (see
below). Another three reactions (P450SCC1m, GTHRDt,
and 3M4HDXPAC) were linked to singleton (dead-end)
metabolites and cannot carry any flux. For the remaining
12 reactions (GTHP, GTHPe, G5SADrm, DCMPDA,
L_LACtm, PDX5PO, PYAM5POr, RADH, RADH2,
RADH3, RADH4, and FACOAL161), however, the thermo-
dynamic constraints represent novel information that can be
used to constrain the feasible flux space.
The reactions showing inconsistency between FVA and
thermodynamics highlight problems in the model. When
4HGLSDm is constrained, no flux is possible through either
PHCHGSm or PHCDm; further analysis revealed that
Recon 1 lacks mitochondrial import for 4-hydroxyprolinensidering directionality constraints in Recon1 that were not
DrG min
(KJ/mol)
DrG max
(KJ/mol) Direction Pathway
þ nad 44.75 100.95 Reverse Arginine and proline
metabolism
31.85 7.66 Forward Transport, mitochondrial
h[c] þ pi[c] 108 8.72 Forward Glutathione metabolism
retn 109.87 29.39 Forward Vitamin A metabolism
retn 86.86 15.97 Forward Vitamin A metabolism
2)h þ nadh 109.87 29.39 Forward Vitamin A metabolism
2)h þ nadph 86.86 15.97 Forward Vitamin A metabolism
l þ nadh 91.83 26.06 Forward Tyrosine metabolism
þ nadph 83.54 12.65 Forward Tyrosine metabolism
)h þ nadph 83.54 12.65 Forward Tyrosine metabolism
h þ nadph 83.54 12.65 Forward Tyrosine metabolism
þ nadph 83.54 12.65 Forward Tyrosine metabolism
ppi 119.89 0.65 Forward Fatty acid metabolism
Thermodynamic Curation of Eukaryotic GeM 499(a degradation product of collagen and other extracellular
matrix proteins) and that flux is restored when this link is
introduced. The three NADP-linked ALDH3 reactions only
function in isolated loops with their irreversible NAD-linked
counterparts (Table S5). The thermodynamic constraints
conflict with the GeM topological constraints (Fig. 1,
Step 5) and no flux is possible through these loops. These iso-
lated loops highlight that the conventional emphasis during
curation on ensuring that reactions carry flux may be flawed,
and a more accurate approach would be to incorporate ther-
modynamics to help curate reactions when biochemical
evidence is lacking. AIRCr is caused by another problem
and will be discussed in a separate section.
Reduced range of metabolite concentration
Initially, a broad range of 104 to 10 mM was allocated for
the concentration of all metabolites in the model. If a metab-
olite is present in more than one compartment, then this
concentration range is applied to the total metabolite
concentration from all compartments, since metabolite
concentrations are typically measured for the whole cell.
Using thermodynamics together with the directions in
Recon 1, NExT narrowed the compartmentalized concentra-
tion ranges of 44 metabolites (Table S6), including six
from central carbon metabolism (3-phosphoglycerate,
ATP, L-Lactate, NAD, NADH, and PPi).
Comparison of reactions found in both compartments
Of the total 110 reactions recorded in both the cytosol and
mitochondria in Recon 1, 33 were found to operate differ-
ently between the cytoplasm and mitochondria (Table S7).
Of these 33 reactions, 30 carry flux only in one cell
compartment due to the network topology, including L-
glutamate 5-semialdehyde dehydratase (G5SAD), a sponta-
neous irreversible reaction (Table 2), which can carry flux
only in mitochondria. Thermodynamically reversible L-
aminoadipate-semialdehyde dehydrogenase (AASAD3) is
topologically constrained in the cytosol due to a link to
the thermodynamically irreversible PPD2CSPp reaction,
whereas the mitochondrial version is part of a different
pathway and unconstrained. Reaction D-glucuronolactone
NAD oxidoreductase was specified in the model as irrevers-
ible in both compartments; however, thermodynamic
analysis only specifies the mitochondrial reaction as irre-
versible. Finally, thermodynamically reversible glutathione
oxidoreductase is topologically free in the cytosol but
topologically constrained in the direction of oxidation of
NADPH in mitochondria. This direction is imposed by
the thermodynamically irreversible mitochondrial gluta-
thione peroxidase (GTHPm) reaction. The cytoplasm iso-
form of glutathione peroxidase is also thermodynamically
irreversible, but in the cytoplasm there are other reactions
that are able to produce oxidized glutathione, removing
the substrate constraint to the glutathione oxidoreductase
reaction.Prediction of irreversible reactions in Yeast 5
model
In this study, the most recently published version of the
yeast consensus GeM, Yeast 5 (16), was selected. Yeast 5
was modified as discussed for the human model, i.e., intro-
duction of IMS, and some minor modifications of equations
to enable accurate calculations. The modified model con-
tains a total of 1891 reactions, whereof 630 are reversible.
Biophysical properties were specified based on literature
values, whereas broad concentration ranges and ratio ranges
for adenylate energy charge and redox factors were used
(Table 1).
De novo predictions
Using NExTwithout the irreversibility constraints specified
in Yeast 5, 124 reactions were identified as irreversible
under physiological conditions (Fig. 1, Step 1). Of these
reactions, 109 were already specified among the 1261 irre-
versible reactions in Yeast 5. Another three reactions were
specified as irreversible in Yeast 5, but in the opposite direc-
tion to that determined by NExT (Table 4, bold reactions).
The remaining 12 reactions were not specified in Yeast 5
(Table 4). Eight of the fifteen reactions with new directions
were also found to be thermodynamically irreversible in
Recon 1 (Tables 2 and 3) linked to arginine and proline
metabolism (r_1871 and r_1888), glutathione metabolism
(r_0483 and r_0484), glycolysis (r_0356), pyrimidine
catabolism (r_0326), vitamin B6 metabolism (r_0955),
and IMP biosynthesis (r_0911). As for the human model,
AIRCr (r_0911) was predicted to operate in the incorrect
direction and will be discussed later. One of the new ther-
modynamically irreversible reactions, DPGM (r_0356),
belongs to the 474 reactions in Yeast 5 that are linked to
singleton metabolites and hence cannot carry flux (Fig. 1,
Step 2).
One of the three reactions (r_1871) for which the direc-
tion was specified differently between thermodynamics
analysis and the model was found in the thermodynamically
correct direction in the human model. If present, acetyl-CoA
hydrolase (r_0110) must operate in the hydrolysis direction.
Acetyl-CoA biosynthesis from CoA and acetate requires
ATP and is covered by a separate reaction encoded by
acetyl-CoA synthetase (r_0112). Cytosolic acetyl-CoA
hydrolase was deleted in the most recent online version,
Yeast 7 GeM, and the same was done in this study. The
reaction pyridoxal oxidase (r_0953) has an extremely high
DrG, and it is thus highly improbable that the model-
specified direction is correct.
Incorporating the 112 thermodynamic constraints into
the network, FVA identified 21 blocked reactions (Table
S8), including four of the new thermodynamically con-
strained reactions (r_0484, r_0955, r_0767, and r_1888)
and one of the reactions with contradicting directions be-
tween thermodynamics and model specifications (r_0953)Biophysical Journal 107(2) 493–503
TABLE 4 Reactions that were identified as irreversible by thermodynamic constraints in Yeast 5 that were not previously specified,
or were specified with the opposite direction in the model
ID Reaction
DrGmin
(KJ/mol)
DrGmax
(KJ/mol) Direction Pathway ID hGeM
r_1871 [m]1p3h5c D h D h2o ¼ 4hglusa 41.44 98.52 Reverse Arginine and proline metabolism PHCHGSm
r_1887 [c]glu5sa ¼ 1pyr5c þ h þ h2o 88.7 31.62 Forward Arginine and proline metabolism G5SADs
r_1888 [m]glu5sa ¼ 1pyr5c þ h þ h2o 90.98 33.9 Forward Arginine and proline metabolism G5SADrm
r_0483 [c] (2)gthrd þ h2o2 ¼ gthox þ (2)h2o 316.29 202.13 Forward Glutathione metabolism GTHP
r_0484 [m] (2)gthrd þ h2o2 ¼ gthox þ (2)h2o 316.29 202.13 Forward Glutathione metabolism GTHPm
r_0356 [c]13dpg ¼ 23dpg þ h 71.96 14.88 Forward Glycolysis/gluconeogenesis DPGM
r_0911 [c]air þ co2tot ¼ 5aizc þ h þ h2o 3.34 71.84 Reverse IMP biosynthesis AIRCr
r_0073 [c]4ppmip þ h2o ¼ (2)h þ minohp þ pi 69.16 0.67 Forward Inositol phosphate metabolism NA
r_0092 [c]6ppmip þ h2o ¼ (2)h þ minohp þ pi 69.16 0.67 Forward Inositol phosphate metabolism NA
r_0767 [n]h2o þ NAD ¼ ADP-rib þ h þ ncam 89.44 3.82 Forward NAD metabolism NADN
r_0204 [c]ap4a þ h2o ¼ (2)adp þ (2)h 102.97 17.35 Forward Nucleotides metabolism ~AP4AH1
r_0326 [c]dcmp þ h þ h2o ¼ dump þ nh4 90.02 4.4 Forward Pyrimidine catabolism DCMPDA
r_0110 [c]acD coaD h ¼ accoaD h2o 15.52 101.14 Reverse Pyruvate metabolism ACOAHi
r_0953 [c]nh4D (0.5)o2D pydxD (2)h2o ¼
(2)h2o2D pydam
306.21 454.62 Reverse Vitamin B6 metabolism NA
r_0955 [c]o2 þ pdx5p ¼ h2o2 þ pydx5p 162.89 65.86 Forward Vitamin B6 metabolism PDX5PO
Reactions in bold are those specified with the opposite direction in the model. See the Supporting Material for analysis of errors in estimated values. NA, not
applicable.
500 Martı´nez et al.(Fig. 1, Step 3). Mitochondrial oxidation of glutathione
(r_0484) was blocked with another four mitochondrial
reactions linked to hydrogen peroxide degradation.
Evidently, Yeast 5 lacks hydrogen-peroxide-forming reac-
tions in mitochondria. The main source of hydrogen
peroxide in mitochondria is from disproportionation of
superoxide (formed as a byproduct of electron transport
chain reactions) by manganese-dependent superoxide dis-
mutase (Mn-SOD) (33); neither the byproduct formation
reaction nor Mn-SOD is included in Yeast 5. The con-
straints in reactions r_0953 and r_0955 together prevent
flux through these reactions and another four reactions
for vitamin B6 metabolism (r_0954, r_0956, r_2025, and
r_2029). These six reactions (r_0953, r_0955, r_0954,
r_0956, r_2025, and r_2029) are part of a closed loop in
Yeast 5 (Table S8), which can be resolved by connecting
pyridoxal-5-phosphate to the network. Cytosolic and
nuclear NAD nucleases (r_1955 and r_0767) are thermody-
namically irreversible in the same direction; these reac-
tions and three more (r_1646, r_2097, and r_1966)
belong to an intercompartment closed loop. Therefore,
the six reactions became blocked. The consequences of
the null flux of r_1888 in the proline metabolism will be
discussed later.
Three new thermodynamically irreversible reactions were
neither blocked nor found irreversible in the human model.
The two depyrophosphorylation reactions (r_0073 and
r_0092) are catalyzed by (EC 3.6.1.52). The same enzyme,
diphosphoinositol-polyphosphate diphosphatase catalyzes
reaction r_0082 (converting 5PP-IP5 to IP6), which is re-
ported as irreversible in both Yeast 5 and Recon 1. The anal-
ogous human reaction to Ap4A hydrolase (r_0204) was
specified in Recon 1 as irreversible, supporting the direction
assigned based on thermodynamics.Biophysical Journal 107(2) 493–503Predictions using the full GeM
The original reversibility constraints of the model were
checked using NExT. Analogous to what was done with
the human model, 54 irreversible intercompartment reac-
tions were assumed reversible. The DrG values for 493 of
1205 remaining irreversible reactions were estimated.
Resolving the three directional conflicts already identified
(Table 4) produced a thermodynamically feasible model.
One new thermodynamically irreversible reaction was iden-
tified in the constrained model, namely fatty-acid-CoA
ligase (hexadecenoate) (r_0403) with a maximum DrG of
0.66 KJ/mol (Fig. 1, Step 4). The new direction is a conse-
quence of the reduction of the cytoplasmic AEC range and
the coenzyme A concentration range by other reactions
specified as irreversible in the network.
The 13 new thermodynamic constraints (r_0403 and
those listed in Table 4) were compared to FVA using the
Yeast 5 directionality constraints only (Fig. 1, Step 5). The
analysis revealed that three reactions are blocked irrespec-
tive of thermodynamics (r_0356, r_0484, and r_0955),
whereas six reactions have conflicting directions between
thermodynamics and FVA (r_0073, r_0092, r_0326,
r_0767, r_0911, and r_1888). The conflicts point to a need
for further curation of these reactions. Thermodynamics
and FVA agreed on the directions specified for three reac-
tions (r_0204, r_0483, and r_1887), and only the new ther-
modynamic constraint on fatty-acid-CoA ligase
(hexadecenoate) adds a new flux constraint to Yeast 5.
Reduced range of metabolite concentration
NExT was used to calculate thermodynamically feasible
concentration ranges of metabolites. The concentration
range of 40 metabolites was significantly narrower than
FIGURE 2 AIRCr. The human enzyme PAIS catalyzes both the AIRCr
and PRASCS reactions (green). The yeast enzyme ADE2 catalyzes the
AIRCr reaction coupled with ATP hydrolysis (purple). The parallel
pathway utilized by bacteria is shown in light blue. These are the three
different ways that different organisms overcome the energy demand to pro-
duce CAIR from AIR.
Thermodynamic Curation of Eukaryotic GeM 501the allocated physiological range (Table S9). Among these
metabolites, nine also had significantly reduced ranges
in the human model (Table S5), including the highly con-
nected cofactors NADH[c], NAD[c], and ATP[c], which
themselves can constrain many reaction directions.
Comparison of reactions in both compartments
There are 73 reactions in Yeast 5 that are present in both the
cytoplasm and mitochondria. Using the network topology
and/or thermodynamic constraints, 19 of these reactions
were predicted to behave differently between the cytoplasm
and mitochondria (Table S10). Network topology alone
prevents flux in one cellular compartment in 13 of the 19
reactions.
Of the remaining six reactions, glutamate 5-semialdehyde
dehydratase will be discussed under proline metabolism in
another section, whereas four of the six reactions are linked
to hydrogen peroxide metabolism. As mentioned above,
mitochondrial glutathione peroxidase (r_0484) is blocked
once thermodynamic irreversibility is considered, since no
hydrogen-peroxide generating reactions have been included
in mitochondria. As a result, several linked irreversible
mitochondrial reactions are unable to carry flux, namely,
hydrogen peroxide reductase (r_0551), thioredoxin reduc-
tase (NADPH) (r_1039), and glutathione oxidoreductase
(r_0482). In the cytosol, other sources of hydrogen peroxide
exist, and the corresponding reactions (r_0481, r_0483,
r_0550, and r_1038) can all carry flux.
The final reaction is aldehyde dehydrogenase, which in
Yeast 5 was listed as irreversible in both compartments.
Although thermodynamics analysis indicates that only the
mitochondrial aldehyde dehydrogenase (r_0175) is thermo-
dynamically irreversible, the cytoplasmic enzyme is revers-
ible due to the different compartmental conditions (pH and
redox potential).Phosphoribosylaminoimidazole carboxylase
(AIRCr and ADE2)
Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21)
is an essential enzyme in purine synthesis in both humans
and yeast (Fig. 2). The estimated DrG, however, contradicts
the expected flux direction (Tables 2 and 4). In Recon 1, the
pathway to produce IMP from PRPP cannot carry flux as a
result of the reverse direction, whereas in Yeast 5 the
pathway can still carry flux but in the opposite direction.
Prokaryotes (e.g., E. coli) use the reactions 5-(carboxya-
mino)imidazole ribonucleotide synthase (EC 6.3.4.18)
and 5-(carboxyamino)imidazole ribonucleotide mutase
(EC 5.4.99.18) to bypass phosphoribosylaminoimidazole
carboxylase (Fig. 2). Although the bypass does not exist
in eukaryotes, two other strategies are used to overcome
the unfavorable thermodynamics. In humans, AIRCr is
carried out by a dual-function enzyme (PAIS) that also cat-
alyzes the thermodynamically favored reaction PRASCS,which has a DrG range of 97.42 to 27.68 KJ/mol under
physiological conditions. This observation suggests that
substrate channelling is being used to couple the unfavor-
able AIRCr reaction with the favorable PRASCS reaction
and that the two reactions should be replaced with a single
combined reaction (Fig. 2).
In yeast, the two enzymes are not coupled. Instead, yeast
uses a variant of AIRCr (ADE2) that hydrolyzes ATP in
stoichiometric proportion to AIR conversion (34). Since
no new EC number has been created for the reaction,
many metabolic models including KEGG and Yeast 5 erro-
neously describe the reaction without ATP, whereas the
Biocyc database for yeast correctly describes it with ATP.
This error has been corrected in the two latest online Yeast
models, 6 and 7.Proline synthesis and degradation pathways
Using NExT, it was possible to unravel a putative role of
yeast compartmentalization for separation of proline synthe-
sis (cytoplasm) and degradation (mitochondria), and the use
of P5CD as a unique degradation pathway. The reaction
G5SAD has an important role in proline metabolism
(Fig. 3). This spontaneous reaction is thermodynamically
irreversible under physiological conditions for both the
human and yeast models. For yeast, the enzyme pyrroline-
5-carboxylate reductase (P5CR) is only found in the cyto-
plasm (35); thus, proline synthesis occurs exclusively in
cytoplasm. Initially, without considering the fixed direction
for G5SAD, there are two possible degradation pathways for
proline in the yeast GeMmodel: direct degradation of 1-pyr-
roline-5-carboxylate to glutamate, or through L-glutamate
5-semialdehyde. Due to the thermodynamically determined
direction for G5SAD (for both compartments), yeast can
only degrade proline using P5CD. Since this enzyme is
strictly mitochondrial for yeast (35), the degradation of pro-
line takes place in mitochondria in yeast.
In contrast to yeast, human cells use only one compart-
ment (mitochondria) for proline synthesis and degradation.Biophysical Journal 107(2) 493–503
FIGURE 3 Proline synthesis and degradation pathways. The sponta-
neous reaction L-glutamate 5-semialdehyde dehydratase (red arrows) has
a fixed direction due to thermodynamic constraints under physiological
conditions for both of the eukaryotic models studied. ARGN, arginase;
G5SAD, L-glutamate 5-semialdehyde dehydratase; G5SD, L-glutamate
5-semialdehyde dehydratase; GLU5K, glutamate 5-kinase; GLYAMDTR,
glycine amidinotransferase; ORNTA, ornithine transaminase; P5CD, 1-
pyrroline-5-carboxylate dehydrogenase; P5CR, pyrroline-5-carboxylate
reductase; PROD2, proline dehydrogenase.
502 Martı´nez et al.In the human model, mitochondrial G5SAD (G5SADm) can
be active due to the presence of ornithine transaminase
(ORNTA) or L-glutamate 5-semialdehyde dehydratase
(G5SD) in the mitochondrial compartment (36–38). Since
ORNTAandG5SD are not present in the cytoplasm, the cyto-
plasmic G5SAD is unable to carry flux. In a similar way, the
enzyme P5CD required for proline catabolism is only local-
ized in mitochondria (36,37). Thus, for human cells, proline
metabolism takes place exclusively in mitochondria.Comparing with previous approaches
The range of estimated DrG values for physiological ranges
of metabolite concentrations have been used to assign direc-
tions to individual reactions in GeMs (11–13). A recent
implementation of this approach is the von Bertalanffy
package (39,40). This corresponds to the first step in the
workflow developed (Fig. 1). As seen in this study, only a
small fraction of the directional constraints can be identified
when using broad metabolite concentrations. Using NET
analysis through NExT and FVA on the full model, it is
possible to evaluate the wider impact of the directional con-
straints in the model.
NET analysis is well suited for open-ended network anal-
ysis, where the gross metabolic phenotype is not specified,
i.e., when we are evaluating and refining a GeM in generic
form. For a specific metabolic study where the direction
of exchange reactions are specified, thermodynamics-
based metabolic flux analysis (TMFA) is a superior algo-Biophysical Journal 107(2) 493–503rithm that directly estimates thermodynamically feasible
metabolic flux distributions from a set of directionality
constraints and a reduced model (25). For eukaryotic
models, TMFA is limited to the use of compartment-specific
metabolite concentration ranges.CONCLUSION
Thermodynamics analysis is a potent tool for validation of
existing irreversibility constraints and identification of
new ones in multicompartment metabolic networks.
We developed an open-source software package for NET
analysis, NExT, which implements correct Gibbs energy
estimations for transport reactions. NExT revealed that pro-
ton transport in the electron transport chain must occur in
the IMS rather than the cytoplasm, and ATP synthase was
modified to use IMS protons.
In two well-curated eukaryotic models, NExT revealed a
few erroneous irreversibility constraints, as well as some
thermodynamically infeasible internal loops. Despite the
use of a broad range of metabolite concentrations, additional
irreversibility constraints were identified, including some
supported by the literature. Improved curation, together
with the new thermodynamic constraints will provide
more accurate flux estimations.
The analysis further highlighted the alternative ap-
proaches used by different organisms to overcome thermo-
dynamic irreversibility of phosphoribosylaminoimidazole
carboxylase using, for example, a parallel pathway
(E. coli), ATP coupling (yeast), and substrate channeling
(human). The analysis also highlighted differences in pro-
line metabolism between yeast (cytosolic anabolism and
mitochondrial catabolism) and humans (exclusively mito-
chondrial metabolism).SUPPORTING MATERIAL
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